Ashish Kulkarni, who is joining the chemical engineering department this fall as an assistant professor, is one of the “Talented 12,” an international team of rising all-stars in chemistry, chosen by Chemical & Engineering News. Kulkarni is nicknamed the “Cancer Crusher” by the magazine.
He comes to UMass Amherst after serving as an instructor of medicine at Harvard Medical School and an associate bioengineer at Brigham and Women’s Hospital in Boston. Kulkarni’s research efforts have been focused on the development of pioneering, structure-activity, relationship-inspired nanomedicine for cancer therapy.
“Disease develops in our body if there is an imbalance in the immune system,” Kulkarni says in his Chemical & Engineering News profile. “I’m developing dual-function nanoparticles that can allow us not only to create a balance in the immune system but also to monitor whether the drug is working in real time.
Kulkarni completed his undergraduate work at the Institute of Chemical Technology in India before earning his doctorate at the University of Cincinnati. Heis the recipient of the Hearst Foundation Young Investigator Award, Dana-Farber/Harvard Cancer Center Career Development Award, American Association of Cancer Research Scholar-in-training Award, American Society of Pharmacology and Experimental Therapeutics Young Scientist Award, and the Melanoma Research Alliance Young Investigator Award.
Chemical & Engineering News is a weekly magazine published by the American Chemical Society. C&EN editors and reporters based in Europe, the U.S., and Asia cover science and technology, business and industry, government and policy, education, and employment aspects of the chemistry field.